πŸ‡ΊπŸ‡Έ FDA
Patent

US 12280120

Tumor-specific cleavable linkers

granted A61KA61K38/00A61K38/2013

Quick answer

US patent 12280120 (Tumor-specific cleavable linkers) held by Xilio Development, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xilio Development, Inc.
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/2013, A61K38/208, A61K38/2086